Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes.

Lp(a) is a unique lipoprotein consisting of an LDL-like particle and a characteristic protein, apo(a). Increased levels of Lp(a) constitute a risk factor for coronary heart disease. Variation in the size of the apo(a) protein is a phenotype controlled by the apo(a) gene on chromosome 6 and is related to Lp(a) plasma levels. Based on 169 MZ and 125 DZ adult female twin pairs, this study's purpose was to estimate the proportion of the variation in Lp(a) levels that is due to genetic influences and to determine the extent to which the apo(a) locus explains this heritability. Lp(a) levels were significantly more similar in MZ twins than in DZ twins: mean co-twin differences were 3.9 +/- 5.7 mg/dl and 16.0 +/- 19.9 mg/dl (P less than .001), respectively. Intraclass correlations were .94 in MZ twins and .32 in DZ twins, resulting in a heritability estimate of .94 (P less than .001). Heritability was then calculated using only co-twins with the same apo(a) phenotype: the heritability estimate decreased to .45 but was still highly significant (P less than .001). Therefore, on the basis of heritability analysis of women twins, Lp(a) levels are almost entirely genetically controlled. Variation at the apo(a) locus contributes to this heritability, although other genetic factors could be involved.

[1]  K. Berg A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. , 2009, Acta pathologica et microbiologica Scandinavica.

[2]  J C Christian,et al.  TWINAN90: a FORTRAN program for conducting ANOVA-based and likelihood-based analyses of twin data. , 1992, Computer methods and programs in biomedicine.

[3]  E. Boerwinkle,et al.  Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. , 1992, The Journal of clinical investigation.

[4]  R. Ferrell,et al.  Expressed hypervariable polymorphism of apolipoprotein (a). , 1991, American journal of human genetics.

[5]  J. Breslow,et al.  Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. , 1991, The Journal of biological chemistry.

[6]  J. Huttunen,et al.  Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants. , 1991, Atherosclerosis.

[7]  J. Sparks,et al.  Effect of weight loss on serum lipoprotein(a) concentrations in an obese population. , 1991, Clinical chemistry.

[8]  E. Boerwinkle,et al.  Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. , 1991, The Journal of clinical investigation.

[9]  D. Rouy,et al.  Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[10]  P. Koskinen,et al.  Characterization of the enzyme activity of human plasma lipoprotein (a) using synthetic peptide substrates. , 1991, The Biochemical journal.

[11]  H. Hoff,et al.  Quantification of apo[a] and apoB in human atherosclerotic lesions. , 1991, Journal of lipid research.

[12]  L. Wilhelmsen,et al.  Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. , 1990, BMJ.

[13]  J. Woo,et al.  Acute and long-term changes in serum lipids after acute stroke. , 1990, Stroke.

[14]  A. Scanu,et al.  Lipoprotein (a). Heterogeneity and biological relevance. , 1990, The Journal of clinical investigation.

[15]  W. Patsch,et al.  Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. , 1990, Journal of lipid research.

[16]  G. Utermann,et al.  Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect. , 1990, Journal of Biological Chemistry.

[17]  A. Vaheri,et al.  Lipoprotein(a) binds to fibronectin and has serine proteinase activity capable of cleaving it. , 1989, The EMBO journal.

[18]  G. Utermann,et al.  The mysteries of lipoprotein(a). , 1989, Science.

[19]  G. Hallmans,et al.  Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population. , 1989, Atherosclerosis.

[20]  A. Hamsten,et al.  Pronounced lowering of serum levels of lipoprotein Lp(a) in hyperlipidaemic subjects treated with nicotinic acid , 1989, Journal of internal medicine.

[21]  M. Dietel,et al.  Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. , 1989, Arteriosclerosis.

[22]  A. Scanu,et al.  A potential basis for the thrombotic risks associated with lipoprotein(a) , 1989, Nature.

[23]  S. Hunt,et al.  Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. , 1989, American journal of epidemiology.

[24]  M. Emi,et al.  Genetic linkage between lipoprotein(a) phenotype and a DNA polymorphism in the plasminogen gene. , 1988, Genomics.

[25]  E. Chen,et al.  cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.

[26]  G. Utermann,et al.  Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. , 1987, The Journal of clinical investigation.

[27]  G. Jürgens,et al.  Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. , 1987, Neurology.

[28]  S B Hulley,et al.  Risk factors for coronary heart disease in adult female twins. Genetic heritability and shared environmental influences. , 1987, American journal of epidemiology.

[29]  N. Morton,et al.  Lp(a) lipoprotein as a risk factor for myocardial infarction. , 1986, JAMA.

[30]  K. Pfeiffer,et al.  Lipoprotein(a) as a strong indicator for cerebrovascular disease. , 1986, Stroke.

[31]  E. Boerwinkle,et al.  Bias of the contribution of single-locus effects to the variance of a quantitative trait. , 1986, American journal of human genetics.

[32]  M. Kameyama,et al.  Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. , 1986, Atherosclerosis.

[33]  H. Brewer,et al.  Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. , 1985, Atherosclerosis.

[34]  J. Opitz,et al.  The genetics of quantitative plasma Lp(a): analysis of a large pedigree. , 1983, American journal of medical genetics.

[35]  G. J. Jones,et al.  The inheritance of sinking‐pre‐beta lipo‐protein and its relation to the Lp(a) antigen * , 1982, Clinical genetics.

[36]  U. Faire,et al.  Complex segregation analysis of the Lp(a)/pre‐ß1‐lipoprotein trait , 1981 .

[37]  A. Børresen,et al.  Lp(a) phenotypes, other lipoprotein parameters, and a family history of coronary heart disease in middle‐aged males , 1979, Clinical genetics.

[38]  J C Christian,et al.  The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. , 1977, American journal of epidemiology.

[39]  W. Hazzard,et al.  Radioimmunoassay of human plasma Lp(a) lipoprotein. , 1977, Journal of lipid research.

[40]  C. Sing,et al.  The genetics of the Lp antigen , 1974, Annals of human genetics.

[41]  C. Sing,et al.  The genetics of the Lp Antigen , 1974, Annals of human genetics.

[42]  J C Christian,et al.  Choice of an estimate of genetic variance from twin data. , 1974, American journal of human genetics.

[43]  N. Morton,et al.  Complex segregation analysis. , 1971, American journal of human genetics.

[44]  K. Berg Lp(a) lipoprotein: an overview. , 1994, Chemistry and physics of lipids.

[45]  G. Assmann,et al.  Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age. , 1990, Clinical chemistry.

[46]  J K Hewitt,et al.  Testing structural equation models for twin data using LISREL , 1989, Behavior genetics.

[47]  R. Fabsitz,et al.  Plasma cholesterol variation in the national heart, lung and blood institute twin study , 1987, Genetic epidemiology.

[48]  N. Morton,et al.  Genetics of the Lp lipoprotein in Japanese‐Americans , 1985, Genetic epidemiology.

[49]  K. Berg Twin studies of coronary heart disease and its risk factors. , 1984, Acta geneticae medicae et gemellologiae.

[50]  E Marth,et al.  Lipoprotein Lp(a) and the risk for myocardial infarction. , 1981, Atherosclerosis.